Document is current
Any future updates will be listed below
-
Authors
Ridgeway, Jennifer L.
Gerdes, Erin O. Wissler
Dodge, Andrew
Liedl, Chad P.
Juntunen, Michael B.
Sundt, Wendy J. S.
Glasgow, Amy
Lampman, Michelle A.
Fink, Angela L.
Severson, Sara B.
Lin, Grace
Sampson, Richard R.
Peterson, Robert P.
Murley, Brian M.
Klassen, Aaron B.
Luke, Anuradha
Friedman, Paul A.
Buechler, Tamara E.
Newman, James S.
McCoy, Rozalina G. https://orcid.org/0000-0002-2289-3183
-
Funding
Funding for this research was provided by:
Mayo Clinic Trials Award Funding
National Center for Advancing Translational Sciences (Grant Number UL1 TR002377)
Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery
- License Information
-
More Information
Article History
Received: 10 August 2022
Accepted: 16 December 2022
First Online: 20 February 2023
Declarations
:
: This study has been approved by the Mayo Clinic Institutional Review Board (IRB# 21–010816). Informed consent to participate will be obtained from all participants.
: Model consent forms are available from the corresponding author upon request.
: The authors declare that they have no competing interests. In the last 36 months, RGM has received support from NIDDK, PCORI, and AARP® for unrelated work. She also serves as a consultant to Emmi® (Wolters Kluwer) on developing patient education materials related to prediabetes and diabetes. In the last 36 months, PAF has received support from or had relationships with Medtronic, Anumana, Eko Health, Alive Cor, Marani Health, Boston Scientific, xAI.health, and MediCool.
